vs
Astrana Health, Inc.(ASTH)与Primerica, Inc.(PRI)财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是Primerica, Inc.的1.1倍($950.5M vs $853.7M),Primerica, Inc.净利率更高(23.1% vs 0.7%,领先22.4%),Astrana Health, Inc.同比增速更快(42.9% vs 11.0%),过去两年Astrana Health, Inc.的营收复合增速更高(53.3% vs 7.2%)
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商,主要服务全美符合联邦医保资格的老年群体,提供上门初级护理、慢性病管理及护理协调服务,致力于提升患者健康水平、降低不必要的医疗支出。
Primerica, Inc.是一家采用多层次营销模式的金融服务机构,业务覆盖美国与加拿大市场,主要面向当地中等收入家庭提供保险、投资等多元化金融产品,满足客户的风险保障与差异化财富管理需求。
ASTH vs PRI — 直观对比
营收规模更大
ASTH
是对方的1.1倍
$853.7M
营收增速更快
ASTH
高出31.9%
11.0%
净利率更高
PRI
高出22.4%
0.7%
两年增速更快
ASTH
近两年复合增速
7.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $950.5M | $853.7M |
| 净利润 | $6.6M | $197.0M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | 28.9% |
| 净利率 | 0.7% | 23.1% |
| 营收同比 | 42.9% | 11.0% |
| 净利润同比 | 184.4% | 17.9% |
| 每股收益(稀释后) | $0.12 | $6.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASTH
PRI
| Q4 25 | $950.5M | $853.7M | ||
| Q3 25 | $956.0M | $839.9M | ||
| Q2 25 | $654.8M | $793.3M | ||
| Q1 25 | $620.4M | $804.8M | ||
| Q4 24 | $665.2M | $768.8M | ||
| Q3 24 | $478.7M | $774.1M | ||
| Q2 24 | $486.3M | $803.4M | ||
| Q1 24 | $404.4M | $742.8M |
净利润
ASTH
PRI
| Q4 25 | $6.6M | $197.0M | ||
| Q3 25 | $373.0K | $206.8M | ||
| Q2 25 | $9.4M | $178.3M | ||
| Q1 25 | $6.7M | $169.1M | ||
| Q4 24 | $-7.8M | $167.1M | ||
| Q3 24 | $16.1M | $164.4M | ||
| Q2 24 | $19.2M | $1.2M | ||
| Q1 24 | $14.8M | $137.9M |
毛利率
ASTH
PRI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 98.0% | ||
| Q1 24 | — | 98.2% |
营业利润率
ASTH
PRI
| Q4 25 | 1.9% | 28.9% | ||
| Q3 25 | 2.0% | 32.3% | ||
| Q2 25 | 3.1% | 29.6% | ||
| Q1 25 | 3.3% | 27.5% | ||
| Q4 24 | 0.1% | 64.7% | ||
| Q3 24 | 5.9% | 32.9% | ||
| Q2 24 | 6.2% | 1.0% | ||
| Q1 24 | 7.5% | 24.1% |
净利率
ASTH
PRI
| Q4 25 | 0.7% | 23.1% | ||
| Q3 25 | 0.0% | 24.6% | ||
| Q2 25 | 1.4% | 22.5% | ||
| Q1 25 | 1.1% | 21.0% | ||
| Q4 24 | -1.2% | 21.7% | ||
| Q3 24 | 3.4% | 21.2% | ||
| Q2 24 | 3.9% | 0.1% | ||
| Q1 24 | 3.7% | 18.6% |
每股收益(稀释后)
ASTH
PRI
| Q4 25 | $0.12 | $6.11 | ||
| Q3 25 | $0.01 | $6.35 | ||
| Q2 25 | $0.19 | $5.40 | ||
| Q1 25 | $0.14 | $5.05 | ||
| Q4 24 | $-0.14 | $4.92 | ||
| Q3 24 | $0.33 | $4.83 | ||
| Q2 24 | $0.40 | $0.03 | ||
| Q1 24 | $0.31 | $3.93 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $756.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $2.4B |
| 总资产 | $2.2B | $15.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ASTH
PRI
| Q4 25 | $429.5M | $756.2M | ||
| Q3 25 | $463.4M | $644.9M | ||
| Q2 25 | $342.1M | $621.2M | ||
| Q1 25 | $260.9M | $625.1M | ||
| Q4 24 | $290.8M | $687.8M | ||
| Q3 24 | $350.3M | $550.1M | ||
| Q2 24 | $327.7M | $627.3M | ||
| Q1 24 | $337.3M | $593.4M |
股东权益
ASTH
PRI
| Q4 25 | $779.3M | $2.4B | ||
| Q3 25 | $775.5M | $2.3B | ||
| Q2 25 | $765.5M | $2.3B | ||
| Q1 25 | $745.4M | $2.3B | ||
| Q4 24 | $712.7M | $2.3B | ||
| Q3 24 | $704.6M | $1.9B | ||
| Q2 24 | $678.9M | $2.1B | ||
| Q1 24 | $653.5M | $2.2B |
总资产
ASTH
PRI
| Q4 25 | $2.2B | $15.0B | ||
| Q3 25 | $2.2B | $14.8B | ||
| Q2 25 | $1.4B | $14.8B | ||
| Q1 25 | $1.3B | $14.6B | ||
| Q4 24 | $1.4B | $14.6B | ||
| Q3 24 | $1.3B | $14.8B | ||
| Q2 24 | $1.3B | $14.6B | ||
| Q1 24 | $1.2B | $14.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $338.2M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | — |
| 自由现金流率自由现金流/营收 | -0.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | -0.44× | 1.72× |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势,按日历期对齐
经营现金流
ASTH
PRI
| Q4 25 | $-2.9M | $338.2M | ||
| Q3 25 | $10.0M | $202.9M | ||
| Q2 25 | $90.9M | $162.6M | ||
| Q1 25 | $16.6M | $197.5M | ||
| Q4 24 | $-10.9M | $270.6M | ||
| Q3 24 | $34.0M | $207.3M | ||
| Q2 24 | $23.2M | $173.3M | ||
| Q1 24 | $6.0M | $210.9M |
自由现金流
ASTH
PRI
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | — | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $5.6M | — |
自由现金流率
ASTH
PRI
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.4% | — |
资本支出强度
ASTH
PRI
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.1% | — |
现金转化率
ASTH
PRI
| Q4 25 | -0.44× | 1.72× | ||
| Q3 25 | 26.69× | 0.98× | ||
| Q2 25 | 9.65× | 0.91× | ||
| Q1 25 | 2.48× | 1.17× | ||
| Q4 24 | — | 1.62× | ||
| Q3 24 | 2.11× | 1.26× | ||
| Q2 24 | 1.21× | 147.98× | ||
| Q1 24 | 0.40× | 1.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
PRI
| Revenues From Sources Other Than Contracts With Customers | $445.9M | 52% |
| Investment And Savings Products Segment Revenues | $340.3M | 40% |
| Other | $56.5M | 7% |
| Segment Revenues From Contracts With Customers | $11.0M | 1% |